{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:23:07Z","timestamp":1793316187185,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"abstract":"<jats:sec>\n            <jats:title>Objective:<\/jats:title>\n            <jats:p>To describe pediatric patients with convulsive refractory status epilepticus in whom there is intention to use an IV anesthetic for seizure control.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design:<\/jats:title>\n            <jats:p>Two-year prospective observational study evaluating patients (age range, 1 mo to 21 yr) with refractory status epilepticus not responding to two antiepileptic drug classes and treated with continuous infusion of anesthetic agent.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Setting:<\/jats:title>\n            <jats:p>Nine pediatric hospitals in the United States.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients:<\/jats:title>\n            <jats:p>In a cohort of 111 patients with refractory status epilepticus (median age, 3.7 yr; 50% male), 54 (49%) underwent continuous infusion of anesthetic treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Main Results:<\/jats:title>\n            <jats:p>The median (interquartile range) ICU length of stay was 10 (3\u201320) days. Up to four \u201ccycles\u201d of serial anesthetic therapy were used, and seizure termination was achieved in 94% by the second cycle. Seizure duration in controlled patients was 5.9 (1.9\u201334) hours for the first cycle and longer when a second cycle was required (30 [4\u2013120] hr; <jats:italic toggle=\"yes\">p<\/jats:italic> = 0.048). Midazolam was the most frequent first-line anesthetic agent (78%); pentobarbital was the most frequently used second-line agent after midazolam failure (82%). An electroencephalographic endpoint was used in over half of the patients; higher midazolam dosing was used with a burst suppression endpoint. In midazolam nonresponders, transition to a second agent occurred after a median of 1 day. Most patients (94%) experienced seizure termination with these two therapies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Midazolam and pentobarbital remain the mainstay of continuous infusion therapy for refractory status epilepticus in the pediatric patient. The majority of patients experience seizure termination within a median of 30 hours. These data have implications for the design and feasibility of future intervention trials. That is, testing a new anesthetic anticonvulsant after failure of both midazolam and pentobarbital is unlikely to be feasible in a pediatric study, whereas a decision to test an alternative to pentobarbital, after midazolam failure, may be possible in a multicenter multinational study.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/pcc.0000000000000900","type":"journal-article","created":{"date-parts":[[2016,8,9]],"date-time":"2016-08-09T16:56:07Z","timestamp":1470761767000},"page":"968-975","source":"Crossref","is-referenced-by-count":51,"title":["Refractory Status Epilepticus in Children: Intention to Treat With Continuous Infusions of Midazolam and Pentobarbital*"],"prefix":"10.1097","volume":"17","author":[{"given":"Robert C.","family":"Tasker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard P.","family":"Goodkin","sequence":"additional","affiliation":[{"name":"The Departments of Neurology and Pediatrics, The University of Virginia Health System, Charlottesville, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"S\u00e1nchez Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Chapman","sequence":"additional","affiliation":[{"name":"The Departments of Pediatrics and Neurology, Children\u2019s Hospital Colorado, University of Colorado School of Medicine, Aurora, CO."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas S.","family":"Abend","sequence":"additional","affiliation":[{"name":"The Division of Neurology, The Children\u2019s Hospital of Philadelphia, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra","family":"Arya","sequence":"additional","affiliation":[{"name":"The Comprehensive Epilepsy Center and Division of Neurology, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Brenton","sequence":"additional","affiliation":[{"name":"The Departments of Neurology and Pediatrics, The University of Virginia Health System, Charlottesville, VA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Carpenter","sequence":"additional","affiliation":[{"name":"The Department of Epilepsy, Neurophysiology, and Critical Care Neurology, Children\u2019s National Medical Center, George Washington University School of Medicine and Health Sciences, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D.","family":"Gaillard","sequence":"additional","affiliation":[{"name":"The Department of Epilepsy, Neurophysiology, and Critical Care Neurology, Children\u2019s National Medical Center, George Washington University School of Medicine and Health Sciences, Washington, DC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy A.","family":"Glauser","sequence":"additional","affiliation":[{"name":"The Comprehensive Epilepsy Center and Division of Neurology, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Division of Neurology and Critical Care, The Department of Pediatrics, Ann & Robert H Lurie Children\u2019s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley R.","family":"Helseth","sequence":"additional","affiliation":[{"name":"The Division of Pediatric Neurology, Duke University Medical Center, Duke University, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele C.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kush","family":"Kapur","sequence":"additional","affiliation":[{"name":"The Division of Epilepsy and Clinical Neurophysiology, Department of Neurology, Boston Children\u2019s Hospital, Harvard Medical School, Boston, MA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad A.","family":"Mikati","sequence":"additional","affiliation":[{"name":"The Division of Pediatric Neurology, Duke University Medical Center, Duke University, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrina","family":"Peariso","sequence":"additional","affiliation":[{"name":"The Comprehensive Epilepsy Center and Division of Neurology, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati, Cincinnati, OH."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Wainwright","sequence":"additional","affiliation":[{"name":"Division of Neurology and Critical Care, The Department of Pediatrics, Ann & Robert H Lurie Children\u2019s Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus A.","family":"Wilfong","sequence":"additional","affiliation":[{"name":"The Departments of Neurology and Pediatrics, Baylor College of Medicine, Texas Children\u2019s Hospital, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korwyn","family":"Williams","sequence":"additional","affiliation":[{"name":"The Department of Pediatric Neurology, Phoenix Children\u2019s Hospital and Barrow Neurological Institute, Phoenix, AZ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Loddenkemper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230823","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s12028-012-9695-z","article-title":"Guidelines for the evaluation and management of status epilepticus.","volume":"17","author":"Brophy","year":"2012","journal-title":"Neurocrit Care"},{"key":"R2-20230823","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ccc.2012.11.007","article-title":"Pediatric intensive care treatment of uncontrolled status epilepticus.","volume":"29","author":"Wilkes","year":"2013","journal-title":"Crit Care Clin"},{"key":"R3-20230823","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1097\/MOP.0000000000000154","article-title":"Pediatric status epilepticus management.","volume":"26","author":"Abend","year":"2014","journal-title":"Curr Opin Pediatr"},{"key":"R4-20230823","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus\u2013Report of the ILAE Task Force on Classification of Status Epilepticus.","volume":"56","author":"Trinka","year":"2015","journal-title":"Epilepsia"},{"key":"R5-20230823","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.seizure.2013.10.004","article-title":"Gaps and opportunities in refractory status epilepticus research in children: A multi-center approach by the Pediatric Status Epilepticus Research Group (pSERG).","volume":"23","author":"S\u00e1nchez Fern\u00e1ndez","year":"2014","journal-title":"Seizure"},{"key":"R6-20230823","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/00003246-199405000-00019","article-title":"Admissions to a pediatric intensive care unit for status epilepticus: A 10-year experience.","volume":"22","author":"Lacroix","year":"1994","journal-title":"Crit Care Med"},{"key":"R7-20230823","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1136\/jnnp.2003.032797","article-title":"Inappropriate emergency management of status epilepticus in children contributes to need for intensive care.","volume":"75","author":"Chin","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R8-20230823","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1212\/01.wnl.0000180959.31355.92","article-title":"Treatment delay and the risk of prolonged status epilepticus.","volume":"65","author":"Eriksson","year":"2005","journal-title":"Neurology"},{"key":"R9-20230823","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S1474-4422(06)70374-X","article-title":"Status epilepticus: Pathophysiology and management in adults.","volume":"5","author":"Chen","year":"2006","journal-title":"Lancet Neurol"},{"key":"R10-20230823","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(06)69043-0","article-title":"Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: Prospective population-based study.","volume":"368","author":"Chin","year":"2006","journal-title":"Lancet"},{"key":"R11-20230823","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/PCC.0000000000000173","article-title":"Intensive care treatment of uncontrolled status epilepticus in children: Systematic literature search of midazolam and anesthetic therapies.","volume":"15","author":"Wilkes","year":"2014","journal-title":"Pediatr Crit Care Med"},{"key":"R12-20230823","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1097\/00003246-199307000-00011","article-title":"Midazolam in the treatment of status epilepticus in children.","volume":"21","author":"Rivera","year":"1993","journal-title":"Crit Care Med"},{"key":"R13-20230823","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1097\/00003246-199909000-00043","article-title":"Midazolam coma for refractory status epilepticus in children.","volume":"27","author":"Igartua","year":"1999","journal-title":"Crit Care Med"},{"key":"R14-20230823","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1177\/088307380201700203","article-title":"Continuous midazolam versus diazepam infusion for refractory convulsive status epilepticus.","volume":"17","author":"Singhi","year":"2002","journal-title":"J Child Neurol"},{"key":"R15-20230823","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/adc.76.5.445","article-title":"Continuous midazolam infusion as treatment of status epilepticus.","volume":"76","author":"Koul","year":"1997","journal-title":"Arch Dis Child"},{"key":"R16-20230823","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1177\/08830738020170123002","article-title":"Eight-year study of childhood status epilepticus: Midazolam infusion in management and outcome.","volume":"17","author":"Koul","year":"2002","journal-title":"J Child Neurol"},{"key":"R17-20230823","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/08830738050200060201","article-title":"Status epilepticus: Clinical analysis of a treatment protocol based on midazolam and phenytoin.","volume":"20","author":"Brevoord","year":"2005","journal-title":"J Child Neurol"},{"key":"R18-20230823","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.seizure.2004.12.005","article-title":"Efficacy of continuous midazolam infusion and mortality in childhood refractory generalized convulsive status epilepticus.","volume":"14","author":"Ozdemir","year":"2005","journal-title":"Seizure"},{"key":"R19-20230823","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1007\/s00134-006-0362-8","article-title":"High-dose midazolam therapy for refractory status epilepticus in children.","volume":"32","author":"Morrison","year":"2006","journal-title":"Intensive Care Med"},{"key":"R20-20230823","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.pediatrneurol.2007.02.012","article-title":"Efficacy of intravenous midazolam for status epilepticus in childhood.","volume":"36","author":"Hayashi","year":"2007","journal-title":"Pediatr Neurol"},{"key":"R21-20230823","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.seizure.2010.10.034","article-title":"Convulsive status epilepticus in children: Etiology, treatment protocol and outcome.","volume":"20","author":"Saz","year":"2011","journal-title":"Seizure"},{"key":"R22-20230823","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4103\/0972-5229.156476","article-title":"Complications during the management of pediatric refractory status epilepticus with benzodiazepine and pentobarbital infusions.","volume":"19","author":"Patten","year":"2015","journal-title":"Indian J Crit Care Med"},{"key":"R23-20230823","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.ejpn.2015.05.007","article-title":"Etiology, clinical course and response to the treatment of status epilepticus in children: A 16-year single-center experience based on 602 episodes of status epilepticus.","volume":"19","author":"Kravljanac","year":"2015","journal-title":"Eur J Paediatr Neurol"},{"key":"R24-20230823","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1212\/WNL.0000000000001673","article-title":"Time from convulsive status epilepticus onset to anticonvulsant administration in children.","volume":"84","author":"S\u00e1nchez Fern\u00e1ndez","year":"2015","journal-title":"Neurology"},{"key":"R25-20230823","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0887-8994(01)00311-3","article-title":"Neurologic outcomes of pediatric epileptic patients with pentobarbital coma.","volume":"25","author":"Kim","year":"2001","journal-title":"Pediatr Neurol"},{"key":"R26-20230823","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1212\/01.wnl.0000173066.89001.f9","article-title":"Propofol and thiopental for refractory status epilepticus in children.","volume":"65","author":"van Gestel","year":"2005","journal-title":"Neurology"},{"key":"R27-20230823","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1600-0404.2009.01198.x","article-title":"Acute encephalitis with refractory, repetitive partial seizures (AERRPS): A peculiar form of childhood encephalitis.","volume":"121","author":"Sakuma","year":"2010","journal-title":"Acta Neurol Scand"},{"key":"R28-20230823","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1177\/0883073811424941","article-title":"Continuous infusion pentobarbital for refractory status epilepticus in children.","volume":"27","author":"Barberio","year":"2012","journal-title":"J Child Neurol"},{"key":"R29-20230823","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1212\/WNL.0000000000000009","article-title":"Anesthetic drugs in status epilepticus: Risk or rescue? A 6-year cohort study.","volume":"82","author":"Sutter","year":"2014","journal-title":"Neurology"},{"key":"R30-20230823","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1186\/cc13883","article-title":"Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: A cohort study.","volume":"18","author":"Pugin","year":"2014","journal-title":"Crit Care"},{"key":"R31-20230823","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1212\/WNL.0000000000000054","article-title":"High-dose midazolam infusion for refractory status epilepticus.","volume":"82","author":"Fernandez","year":"2014","journal-title":"Neurology"},{"key":"R32-20230823","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.jocn.2014.11.007","article-title":"Induction of burst suppression or coma using intravenous anesthetics in refractory status epilepticus.","volume":"22","author":"Kang","year":"2015","journal-title":"J Clin Neurosci"},{"key":"R33-20230823","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1097\/CCM.0000000000000881","article-title":"Status epilepticus: Impact of therapeutic coma on outcome.","volume":"43","author":"Marchi","year":"2015","journal-title":"Crit Care Med"}],"container-title":["Pediatric Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00130478-201610000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T23:09:32Z","timestamp":1692832172000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00130478-201610000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pcc.0000000000000900","relation":{},"ISSN":["1529-7535"],"issn-type":[{"value":"1529-7535","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]}}}